Immune and clinicopathological features of molecularly defined prolactinoma subtypes
pubmed: wnt1 2026-07-11
Summary:
CONCLUSIONS: Genomic profiling revealed two distinct prolactinoma subtypes-stemness (G1) and proliferative (G2)-with divergent immune landscapes and clinical behaviors. These findings offer a foundation for molecularly informed, individualized therapeutic strategies.